Tommaso Priamo obtained his Bachelor’s degree in Biotechnology at “Università degli Studi di Roma Tor Vergata” in 2021 and his Master’s degree in Medical Biotechnology at Sapienza University of Rome, discussing a thesis focused on the evaluation of the antitumoral and immunostimolatory effects of novel dual inhibitors of histone deacetylase and PD-L1 as a possible form of immunotherapy.

In 2024 Tommaso joined the Tumor Microenvironment Lab led by Diletta Di Mitri at Humanitas Research Hospital, where he is currently working as a pre-doctoral fellow.